Heineman Thomas Charles (CIK 2103579) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy ONCY (12,132 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | ONCOLYTICS BIOTECH INC (ONCY) | Chief Medical Officer | Buy | 12,132 | $10,070 |
Source: SEC Form 4 filings · as of 2026-02-13